nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—PTGS1—malignant glioma	0.514	0.636	CbGaD
Mefenamic acid—PTGS2—malignant glioma	0.294	0.364	CbGaD
Mefenamic acid—Meningitis—Carmustine—malignant glioma	0.00383	0.0486	CcSEcCtD
Mefenamic acid—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00152	0.0192	CcSEcCtD
Mefenamic acid—Hearing impaired—Temozolomide—malignant glioma	0.00151	0.0191	CcSEcCtD
Mefenamic acid—Coma—Carmustine—malignant glioma	0.00136	0.0172	CcSEcCtD
Mefenamic acid—Aplastic anaemia—Temozolomide—malignant glioma	0.00135	0.0171	CcSEcCtD
Mefenamic acid—Sepsis—Carmustine—malignant glioma	0.00129	0.0163	CcSEcCtD
Mefenamic acid—Ear pain—Temozolomide—malignant glioma	0.00122	0.0155	CcSEcCtD
Mefenamic acid—Vascular purpura—Temozolomide—malignant glioma	0.00116	0.0148	CcSEcCtD
Mefenamic acid—Deafness—Temozolomide—malignant glioma	0.00116	0.0148	CcSEcCtD
Mefenamic acid—Hepatic failure—Temozolomide—malignant glioma	0.00116	0.0147	CcSEcCtD
Mefenamic acid—Dermatitis exfoliative—Temozolomide—malignant glioma	0.0011	0.014	CcSEcCtD
Mefenamic acid—Hyponatraemia—Carmustine—malignant glioma	0.00108	0.0137	CcSEcCtD
Mefenamic acid—Purpura—Temozolomide—malignant glioma	0.00108	0.0137	CcSEcCtD
Mefenamic acid—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00108	0.0137	CcSEcCtD
Mefenamic acid—Liver function test abnormal—Carmustine—malignant glioma	0.000995	0.0126	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000937	0.0119	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—TP53—malignant glioma	0.000916	0.0841	CrCbGaD
Mefenamic acid—Pancytopenia—Carmustine—malignant glioma	0.000884	0.0112	CcSEcCtD
Mefenamic acid—Pancytopenia—Temozolomide—malignant glioma	0.000854	0.0108	CcSEcCtD
Mefenamic acid—Dysuria—Temozolomide—malignant glioma	0.000841	0.0107	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Carmustine—malignant glioma	0.00084	0.0107	CcSEcCtD
Mefenamic acid—Pneumonia—Carmustine—malignant glioma	0.000835	0.0106	CcSEcCtD
Mefenamic acid—Floctafenine—PTGS1—malignant glioma	0.000823	0.0757	CrCbGaD
Mefenamic acid—Photosensitivity reaction—Temozolomide—malignant glioma	0.000821	0.0104	CcSEcCtD
Mefenamic acid—Renal failure—Carmustine—malignant glioma	0.000816	0.0104	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Temozolomide—malignant glioma	0.000812	0.0103	CcSEcCtD
Mefenamic acid—Stomatitis—Carmustine—malignant glioma	0.000809	0.0103	CcSEcCtD
Mefenamic acid—Pneumonia—Temozolomide—malignant glioma	0.000807	0.0102	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000795	0.0101	CcSEcCtD
Mefenamic acid—Stomatitis—Temozolomide—malignant glioma	0.000782	0.00992	CcSEcCtD
Mefenamic acid—Haemoglobin—Carmustine—malignant glioma	0.000749	0.0095	CcSEcCtD
Mefenamic acid—Haemorrhage—Carmustine—malignant glioma	0.000745	0.00945	CcSEcCtD
Mefenamic acid—Hallucination—Carmustine—malignant glioma	0.000742	0.00941	CcSEcCtD
Mefenamic acid—Haemoglobin—Temozolomide—malignant glioma	0.000724	0.00918	CcSEcCtD
Mefenamic acid—Haemorrhage—Temozolomide—malignant glioma	0.00072	0.00914	CcSEcCtD
Mefenamic acid—Hepatitis—Temozolomide—malignant glioma	0.00072	0.00914	CcSEcCtD
Mefenamic acid—Hallucination—Temozolomide—malignant glioma	0.000717	0.00909	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Temozolomide—malignant glioma	0.000711	0.00902	CcSEcCtD
Mefenamic acid—Urethral disorder—Temozolomide—malignant glioma	0.000706	0.00896	CcSEcCtD
Mefenamic acid—Erythema multiforme—Temozolomide—malignant glioma	0.000681	0.00864	CcSEcCtD
Mefenamic acid—Tinnitus—Temozolomide—malignant glioma	0.000671	0.00852	CcSEcCtD
Mefenamic acid—Arrhythmia—Carmustine—malignant glioma	0.000666	0.00845	CcSEcCtD
Mefenamic acid—Alopecia—Carmustine—malignant glioma	0.000659	0.00835	CcSEcCtD
Mefenamic acid—Mental disorder—Carmustine—malignant glioma	0.000653	0.00828	CcSEcCtD
Mefenamic acid—Alopecia—Temozolomide—malignant glioma	0.000636	0.00807	CcSEcCtD
Mefenamic acid—Mental disorder—Temozolomide—malignant glioma	0.000631	0.008	CcSEcCtD
Mefenamic acid—Vision blurred—Carmustine—malignant glioma	0.000611	0.00776	CcSEcCtD
Mefenamic acid—Tremor—Carmustine—malignant glioma	0.000608	0.00771	CcSEcCtD
Mefenamic acid—Anaemia—Carmustine—malignant glioma	0.0006	0.00761	CcSEcCtD
Mefenamic acid—Vision blurred—Temozolomide—malignant glioma	0.000591	0.0075	CcSEcCtD
Mefenamic acid—Tremor—Temozolomide—malignant glioma	0.000587	0.00745	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Temozolomide—malignant glioma	0.000582	0.00738	CcSEcCtD
Mefenamic acid—Leukopenia—Carmustine—malignant glioma	0.000581	0.00737	CcSEcCtD
Mefenamic acid—Anaemia—Temozolomide—malignant glioma	0.000579	0.00735	CcSEcCtD
Mefenamic acid—Angioedema—Temozolomide—malignant glioma	0.000573	0.00727	CcSEcCtD
Mefenamic acid—Malaise—Temozolomide—malignant glioma	0.000565	0.00717	CcSEcCtD
Mefenamic acid—Vertigo—Temozolomide—malignant glioma	0.000563	0.00715	CcSEcCtD
Mefenamic acid—Convulsion—Carmustine—malignant glioma	0.000562	0.00713	CcSEcCtD
Mefenamic acid—Leukopenia—Temozolomide—malignant glioma	0.000561	0.00712	CcSEcCtD
Mefenamic acid—Hypertension—Carmustine—malignant glioma	0.00056	0.00711	CcSEcCtD
Mefenamic acid—Palpitations—Temozolomide—malignant glioma	0.000554	0.00703	CcSEcCtD
Mefenamic acid—Anxiety—Carmustine—malignant glioma	0.00055	0.00698	CcSEcCtD
Mefenamic acid—Convulsion—Temozolomide—malignant glioma	0.000543	0.00689	CcSEcCtD
Mefenamic acid—Hypertension—Temozolomide—malignant glioma	0.000541	0.00687	CcSEcCtD
Mefenamic acid—Confusional state—Carmustine—malignant glioma	0.000534	0.00677	CcSEcCtD
Mefenamic acid—Anxiety—Temozolomide—malignant glioma	0.000532	0.00675	CcSEcCtD
Mefenamic acid—Tiaprofenic acid—PTGS1—malignant glioma	0.000531	0.0488	CrCbGaD
Mefenamic acid—Lumiracoxib—PTGS1—malignant glioma	0.000531	0.0488	CrCbGaD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00053	0.00672	CcSEcCtD
Mefenamic acid—Oedema—Carmustine—malignant glioma	0.000529	0.00672	CcSEcCtD
Mefenamic acid—Discomfort—Temozolomide—malignant glioma	0.000527	0.00669	CcSEcCtD
Mefenamic acid—Infection—Carmustine—malignant glioma	0.000526	0.00667	CcSEcCtD
Mefenamic acid—Dry mouth—Temozolomide—malignant glioma	0.000522	0.00662	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Carmustine—malignant glioma	0.000518	0.00658	CcSEcCtD
Mefenamic acid—Tachycardia—Carmustine—malignant glioma	0.000517	0.00656	CcSEcCtD
Mefenamic acid—Confusional state—Temozolomide—malignant glioma	0.000516	0.00655	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Temozolomide—malignant glioma	0.000512	0.00649	CcSEcCtD
Mefenamic acid—Oedema—Temozolomide—malignant glioma	0.000512	0.00649	CcSEcCtD
Mefenamic acid—Infection—Temozolomide—malignant glioma	0.000508	0.00645	CcSEcCtD
Mefenamic acid—Nepafenac—PTGS1—malignant glioma	0.000505	0.0464	CrCbGaD
Mefenamic acid—Anorexia—Carmustine—malignant glioma	0.000505	0.0064	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Temozolomide—malignant glioma	0.000501	0.00636	CcSEcCtD
Mefenamic acid—Skin disorder—Temozolomide—malignant glioma	0.000497	0.00631	CcSEcCtD
Mefenamic acid—Hypotension—Carmustine—malignant glioma	0.000495	0.00628	CcSEcCtD
Mefenamic acid—Anorexia—Temozolomide—malignant glioma	0.000488	0.00619	CcSEcCtD
Mefenamic acid—Insomnia—Carmustine—malignant glioma	0.000479	0.00608	CcSEcCtD
Mefenamic acid—Paraesthesia—Carmustine—malignant glioma	0.000475	0.00603	CcSEcCtD
Mefenamic acid—Niflumic Acid—PTGS1—malignant glioma	0.000473	0.0435	CrCbGaD
Mefenamic acid—Diclofenac—CYP2C18—malignant glioma	0.000473	0.0435	CrCbGaD
Mefenamic acid—Dyspnoea—Carmustine—malignant glioma	0.000472	0.00599	CcSEcCtD
Mefenamic acid—Floctafenine—PTGS2—malignant glioma	0.000471	0.0432	CrCbGaD
Mefenamic acid—Somnolence—Carmustine—malignant glioma	0.000471	0.00597	CcSEcCtD
Mefenamic acid—Insomnia—Temozolomide—malignant glioma	0.000463	0.00587	CcSEcCtD
Mefenamic acid—Decreased appetite—Carmustine—malignant glioma	0.00046	0.00584	CcSEcCtD
Mefenamic acid—Paraesthesia—Temozolomide—malignant glioma	0.000459	0.00583	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Carmustine—malignant glioma	0.000457	0.0058	CcSEcCtD
Mefenamic acid—Dyspnoea—Temozolomide—malignant glioma	0.000456	0.00579	CcSEcCtD
Mefenamic acid—Somnolence—Temozolomide—malignant glioma	0.000455	0.00577	CcSEcCtD
Mefenamic acid—Constipation—Carmustine—malignant glioma	0.000453	0.00574	CcSEcCtD
Mefenamic acid—Diclofenac—CXCL8—malignant glioma	0.000453	0.0416	CrCbGaD
Mefenamic acid—Dyspepsia—Temozolomide—malignant glioma	0.00045	0.00571	CcSEcCtD
Mefenamic acid—Decreased appetite—Temozolomide—malignant glioma	0.000445	0.00564	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000442	0.0056	CcSEcCtD
Mefenamic acid—Constipation—Temozolomide—malignant glioma	0.000438	0.00555	CcSEcCtD
Mefenamic acid—Feeling abnormal—Carmustine—malignant glioma	0.000436	0.00554	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Carmustine—malignant glioma	0.000433	0.00549	CcSEcCtD
Mefenamic acid—Feeling abnormal—Temozolomide—malignant glioma	0.000422	0.00535	CcSEcCtD
Mefenamic acid—Salsalate—PTGS1—malignant glioma	0.000419	0.0385	CrCbGaD
Mefenamic acid—Body temperature increased—Carmustine—malignant glioma	0.000419	0.00531	CcSEcCtD
Mefenamic acid—Abdominal pain—Carmustine—malignant glioma	0.000419	0.00531	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Temozolomide—malignant glioma	0.000418	0.00531	CcSEcCtD
Mefenamic acid—Meclofenamic acid—PTGS1—malignant glioma	0.000413	0.038	CrCbGaD
Mefenamic acid—Urticaria—Temozolomide—malignant glioma	0.000406	0.00516	CcSEcCtD
Mefenamic acid—Body temperature increased—Temozolomide—malignant glioma	0.000404	0.00513	CcSEcCtD
Mefenamic acid—Abdominal pain—Temozolomide—malignant glioma	0.000404	0.00513	CcSEcCtD
Mefenamic acid—Ketoprofen—CXCL8—malignant glioma	0.000401	0.0368	CrCbGaD
Mefenamic acid—Asthenia—Carmustine—malignant glioma	0.00038	0.00482	CcSEcCtD
Mefenamic acid—Asthenia—Temozolomide—malignant glioma	0.000367	0.00466	CcSEcCtD
Mefenamic acid—Diarrhoea—Carmustine—malignant glioma	0.000362	0.0046	CcSEcCtD
Mefenamic acid—Pruritus—Temozolomide—malignant glioma	0.000362	0.00459	CcSEcCtD
Mefenamic acid—Diclofenac—CYP2B6—malignant glioma	0.000351	0.0323	CrCbGaD
Mefenamic acid—Dizziness—Carmustine—malignant glioma	0.00035	0.00444	CcSEcCtD
Mefenamic acid—Diarrhoea—Temozolomide—malignant glioma	0.00035	0.00444	CcSEcCtD
Mefenamic acid—Fenoprofen—PTGS1—malignant glioma	0.000347	0.0318	CrCbGaD
Mefenamic acid—Dizziness—Temozolomide—malignant glioma	0.000338	0.00429	CcSEcCtD
Mefenamic acid—Vomiting—Carmustine—malignant glioma	0.000337	0.00427	CcSEcCtD
Mefenamic acid—Rash—Carmustine—malignant glioma	0.000334	0.00424	CcSEcCtD
Mefenamic acid—Dermatitis—Carmustine—malignant glioma	0.000334	0.00423	CcSEcCtD
Mefenamic acid—Headache—Carmustine—malignant glioma	0.000332	0.00421	CcSEcCtD
Mefenamic acid—Vomiting—Temozolomide—malignant glioma	0.000325	0.00413	CcSEcCtD
Mefenamic acid—Rash—Temozolomide—malignant glioma	0.000323	0.00409	CcSEcCtD
Mefenamic acid—Dermatitis—Temozolomide—malignant glioma	0.000322	0.00409	CcSEcCtD
Mefenamic acid—Headache—Temozolomide—malignant glioma	0.000321	0.00407	CcSEcCtD
Mefenamic acid—Nausea—Carmustine—malignant glioma	0.000314	0.00399	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—PTGS1—malignant glioma	0.000313	0.0288	CrCbGaD
Mefenamic acid—Nausea—Temozolomide—malignant glioma	0.000304	0.00386	CcSEcCtD
Mefenamic acid—Tiaprofenic acid—PTGS2—malignant glioma	0.000303	0.0279	CrCbGaD
Mefenamic acid—Lumiracoxib—PTGS2—malignant glioma	0.000303	0.0279	CrCbGaD
Mefenamic acid—Nepafenac—PTGS2—malignant glioma	0.000289	0.0265	CrCbGaD
Mefenamic acid—Niflumic Acid—PTGS2—malignant glioma	0.00027	0.0248	CrCbGaD
Mefenamic acid—Salicylic acid—PTGS1—malignant glioma	0.000258	0.0237	CrCbGaD
Mefenamic acid—Salsalate—PTGS2—malignant glioma	0.00024	0.022	CrCbGaD
Mefenamic acid—Meclofenamic acid—PTGS2—malignant glioma	0.000236	0.0217	CrCbGaD
Mefenamic acid—Diclofenac—PTGS1—malignant glioma	0.000231	0.0212	CrCbGaD
Mefenamic acid—Flurbiprofen—PTGS1—malignant glioma	0.000226	0.0208	CrCbGaD
Mefenamic acid—Ketoprofen—PTGS1—malignant glioma	0.000205	0.0188	CrCbGaD
Mefenamic acid—Fenoprofen—PTGS2—malignant glioma	0.000198	0.0182	CrCbGaD
Mefenamic acid—Acetylsalicylic acid—PTGS2—malignant glioma	0.000179	0.0165	CrCbGaD
Mefenamic acid—Salicylic acid—PTGS2—malignant glioma	0.000147	0.0136	CrCbGaD
Mefenamic acid—Diclofenac—PTGS2—malignant glioma	0.000132	0.0121	CrCbGaD
Mefenamic acid—Flurbiprofen—PTGS2—malignant glioma	0.000129	0.0119	CrCbGaD
Mefenamic acid—Ketoprofen—PTGS2—malignant glioma	0.000117	0.0107	CrCbGaD
Mefenamic acid—AKR1C3—Disease—AKT2—malignant glioma	3.78e-05	0.000372	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CD—malignant glioma	3.78e-05	0.000372	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HEY1—malignant glioma	3.74e-05	0.000367	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PDGFRA—malignant glioma	3.74e-05	0.000367	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.72e-05	0.000365	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—STAT3—malignant glioma	3.64e-05	0.000357	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PIK3CD—malignant glioma	3.64e-05	0.000357	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.63e-05	0.000357	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HIST1H3B—malignant glioma	3.63e-05	0.000356	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SPP1—malignant glioma	3.63e-05	0.000356	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—FGF2—malignant glioma	3.62e-05	0.000356	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.62e-05	0.000355	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP2B6—malignant glioma	3.61e-05	0.000354	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.54e-05	0.000348	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.53e-05	0.000346	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—FGF2—malignant glioma	3.48e-05	0.000342	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.46e-05	0.00034	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CG—malignant glioma	3.46e-05	0.00034	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TERT—malignant glioma	3.44e-05	0.000338	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PTEN—malignant glioma	3.41e-05	0.000335	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MDM2—malignant glioma	3.39e-05	0.000333	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.39e-05	0.000332	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MYC—malignant glioma	3.38e-05	0.000332	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—RAF1—malignant glioma	3.38e-05	0.000332	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PDGFB—malignant glioma	3.36e-05	0.000329	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ASMT—malignant glioma	3.35e-05	0.000329	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PPARG—malignant glioma	3.34e-05	0.000328	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—ERBB2—malignant glioma	3.34e-05	0.000328	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—FGFR1—malignant glioma	3.34e-05	0.000328	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—JAG2—malignant glioma	3.31e-05	0.000325	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—EGFR—malignant glioma	3.31e-05	0.000325	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—IDH1—malignant glioma	3.3e-05	0.000324	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.3e-05	0.000324	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CB—malignant glioma	3.3e-05	0.000324	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HIF1A—malignant glioma	3.29e-05	0.000323	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.28e-05	0.000322	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PIK3CA—malignant glioma	3.28e-05	0.000322	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.27e-05	0.000321	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.27e-05	0.000321	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MDM2—malignant glioma	3.26e-05	0.00032	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—RAF1—malignant glioma	3.25e-05	0.000319	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—ERBB2—malignant glioma	3.21e-05	0.000315	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SPHK1—malignant glioma	3.19e-05	0.000314	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTT1—malignant glioma	3.19e-05	0.000313	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CAV1—malignant glioma	3.18e-05	0.000312	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CXCL8—malignant glioma	3.17e-05	0.000311	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PIK3CB—malignant glioma	3.17e-05	0.000311	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—BCAN—malignant glioma	3.15e-05	0.00031	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—KDR—malignant glioma	3.14e-05	0.000309	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTGS2—malignant glioma	3.14e-05	0.000308	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP2C18—malignant glioma	3.13e-05	0.000307	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—KRAS—malignant glioma	3.13e-05	0.000307	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—IDH2—malignant glioma	3.12e-05	0.000307	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CD—malignant glioma	3.05e-05	0.000299	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CASP3—malignant glioma	3.03e-05	0.000298	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL2—malignant glioma	3.03e-05	0.000297	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—F2—malignant glioma	3.03e-05	0.000297	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—FN1—malignant glioma	3.03e-05	0.000297	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.01e-05	0.000295	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—BAD—malignant glioma	2.99e-05	0.000294	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.98e-05	0.000292	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NOTCH1—malignant glioma	2.96e-05	0.000291	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.95e-05	0.00029	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.95e-05	0.000289	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP2B6—malignant glioma	2.94e-05	0.000288	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.91e-05	0.000286	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CD80—malignant glioma	2.9e-05	0.000285	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CG—malignant glioma	2.9e-05	0.000284	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—APC—malignant glioma	2.9e-05	0.000284	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PIK3CA—malignant glioma	2.87e-05	0.000282	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MMP9—malignant glioma	2.87e-05	0.000281	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EGF—malignant glioma	2.86e-05	0.000281	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PTEN—malignant glioma	2.85e-05	0.00028	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PTPN11—malignant glioma	2.85e-05	0.000279	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—H3F3A—malignant glioma	2.8e-05	0.000275	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—BCHE—malignant glioma	2.78e-05	0.000273	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—SLC5A5—malignant glioma	2.74e-05	0.000269	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTEN—malignant glioma	2.74e-05	0.000269	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—BRAF—malignant glioma	2.72e-05	0.000267	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.69e-05	0.000264	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—IDH1—malignant glioma	2.69e-05	0.000264	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—AKT1—malignant glioma	2.68e-05	0.000263	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CB—malignant glioma	2.65e-05	0.000261	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—AKT2—malignant glioma	2.65e-05	0.00026	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—JAG1—malignant glioma	2.64e-05	0.00026	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTGS2—malignant glioma	2.63e-05	0.000258	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SPHK1—malignant glioma	2.6e-05	0.000255	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.59e-05	0.000255	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.59e-05	0.000255	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—FBXW7—malignant glioma	2.59e-05	0.000254	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—malignant glioma	2.57e-05	0.000253	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.57e-05	0.000252	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—STAT3—malignant glioma	2.55e-05	0.00025	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CD—malignant glioma	2.55e-05	0.00025	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP2C18—malignant glioma	2.55e-05	0.00025	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—IDH2—malignant glioma	2.54e-05	0.00025	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTT1—malignant glioma	2.53e-05	0.000248	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.46e-05	0.000241	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—STAT3—malignant glioma	2.45e-05	0.00024	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—FGF2—malignant glioma	2.44e-05	0.000239	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PIK3CA—malignant glioma	2.4e-05	0.000236	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.4e-05	0.000236	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.4e-05	0.000235	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.39e-05	0.000235	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PTGS1—malignant glioma	2.37e-05	0.000233	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MYC—malignant glioma	2.37e-05	0.000233	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.36e-05	0.000232	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—AKT1—malignant glioma	2.35e-05	0.00023	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EGFR—malignant glioma	2.32e-05	0.000227	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTEN—malignant glioma	2.29e-05	0.000225	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MDM2—malignant glioma	2.28e-05	0.000224	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MYC—malignant glioma	2.28e-05	0.000223	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—RAF1—malignant glioma	2.27e-05	0.000223	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ERBB2—malignant glioma	2.25e-05	0.000221	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.24e-05	0.00022	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—EGFR—malignant glioma	2.23e-05	0.000219	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CB—malignant glioma	2.22e-05	0.000218	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTP1—malignant glioma	2.21e-05	0.000217	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—BCHE—malignant glioma	2.2e-05	0.000216	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—KRAS—malignant glioma	2.19e-05	0.000215	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.19e-05	0.000215	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—IDH1—malignant glioma	2.19e-05	0.000215	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SLC5A5—malignant glioma	2.18e-05	0.000214	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CAT—malignant glioma	2.15e-05	0.000211	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CXCL8—malignant glioma	2.13e-05	0.000209	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SPHK1—malignant glioma	2.12e-05	0.000208	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.11e-05	0.000207	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—KRAS—malignant glioma	2.1e-05	0.000206	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP2C18—malignant glioma	2.07e-05	0.000203	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.06e-05	0.000202	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTT1—malignant glioma	2.06e-05	0.000202	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CASP3—malignant glioma	2.04e-05	0.0002	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL2—malignant glioma	2.04e-05	0.0002	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—NCOR1—malignant glioma	2.03e-05	0.000199	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CDKN2B—malignant glioma	2.03e-05	0.000199	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CA—malignant glioma	2.01e-05	0.000197	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—AKT1—malignant glioma	1.96e-05	0.000193	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.95e-05	0.000192	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TP53—malignant glioma	1.95e-05	0.000191	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HES1—malignant glioma	1.94e-05	0.00019	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PIK3CA—malignant glioma	1.93e-05	0.00019	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS1—malignant glioma	1.93e-05	0.000189	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MMP9—malignant glioma	1.93e-05	0.000189	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NCOR1—malignant glioma	1.92e-05	0.000189	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.92e-05	0.000189	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PTEN—malignant glioma	1.92e-05	0.000188	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PDGFRA—malignant glioma	1.84e-05	0.000181	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—BCHE—malignant glioma	1.79e-05	0.000176	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.78e-05	0.000175	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.78e-05	0.000175	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.77e-05	0.000174	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTP1—malignant glioma	1.75e-05	0.000172	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—malignant glioma	1.73e-05	0.00017	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.72e-05	0.000169	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—STAT3—malignant glioma	1.72e-05	0.000168	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CAT—malignant glioma	1.71e-05	0.000168	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TERT—malignant glioma	1.7e-05	0.000167	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HLA-A—malignant glioma	1.7e-05	0.000167	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTT1—malignant glioma	1.68e-05	0.000165	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.68e-05	0.000165	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.66e-05	0.000163	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PDGFB—malignant glioma	1.66e-05	0.000163	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CAV1—malignant glioma	1.66e-05	0.000163	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—FGFR1—malignant glioma	1.65e-05	0.000162	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—AKT1—malignant glioma	1.64e-05	0.000161	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HIF1A—malignant glioma	1.62e-05	0.000159	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CA—malignant glioma	1.62e-05	0.000159	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—NCOR1—malignant glioma	1.61e-05	0.000158	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MYC—malignant glioma	1.59e-05	0.000156	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.58e-05	0.000155	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—AKT1—malignant glioma	1.58e-05	0.000155	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS1—malignant glioma	1.57e-05	0.000154	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CAV1—malignant glioma	1.57e-05	0.000154	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.56e-05	0.000154	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EGFR—malignant glioma	1.56e-05	0.000153	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CG—malignant glioma	1.51e-05	0.000148	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—BAD—malignant glioma	1.48e-05	0.000145	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—KRAS—malignant glioma	1.47e-05	0.000145	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOTCH1—malignant glioma	1.46e-05	0.000144	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—BCHE—malignant glioma	1.46e-05	0.000143	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPARG—malignant glioma	1.46e-05	0.000143	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.45e-05	0.000142	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.44e-05	0.000142	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CD80—malignant glioma	1.43e-05	0.000141	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APC—malignant glioma	1.43e-05	0.00014	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTP1—malignant glioma	1.43e-05	0.00014	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EGF—malignant glioma	1.41e-05	0.000139	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PTPN11—malignant glioma	1.4e-05	0.000138	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CAT—malignant glioma	1.39e-05	0.000136	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.36e-05	0.000134	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CA—malignant glioma	1.35e-05	0.000133	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.35e-05	0.000133	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—BRAF—malignant glioma	1.34e-05	0.000132	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CD—malignant glioma	1.33e-05	0.00013	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—AKT1—malignant glioma	1.32e-05	0.00013	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CAV1—malignant glioma	1.31e-05	0.000129	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NCOR1—malignant glioma	1.31e-05	0.000129	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TP53—malignant glioma	1.31e-05	0.000129	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—AKT2—malignant glioma	1.31e-05	0.000128	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PIK3CD—malignant glioma	1.26e-05	0.000123	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.26e-05	0.000123	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—FGF2—malignant glioma	1.2e-05	0.000118	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CG—malignant glioma	1.2e-05	0.000118	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.18e-05	0.000116	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTP1—malignant glioma	1.16e-05	0.000114	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CB—malignant glioma	1.16e-05	0.000113	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPARG—malignant glioma	1.16e-05	0.000113	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTGS2—malignant glioma	1.14e-05	0.000112	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CAT—malignant glioma	1.13e-05	0.000111	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MDM2—malignant glioma	1.13e-05	0.000111	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—RAF1—malignant glioma	1.12e-05	0.00011	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ERBB2—malignant glioma	1.11e-05	0.000109	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—AKT1—malignant glioma	1.11e-05	0.000109	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PIK3CB—malignant glioma	1.1e-05	0.000108	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CAV1—malignant glioma	1.07e-05	0.000105	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NCOR1—malignant glioma	1.07e-05	0.000105	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CD—malignant glioma	1.05e-05	0.000103	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.02e-05	0.0001	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTEN—malignant glioma	9.98e-06	9.8e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CG—malignant glioma	9.74e-06	9.56e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PTEN—malignant glioma	9.46e-06	9.29e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPARG—malignant glioma	9.4e-06	9.23e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CB—malignant glioma	9.17e-06	9.01e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CAV1—malignant glioma	8.7e-06	8.54e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CD—malignant glioma	8.56e-06	8.41e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—STAT3—malignant glioma	8.46e-06	8.31e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.31e-06	8.16e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CG—malignant glioma	7.93e-06	7.78e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PTEN—malignant glioma	7.93e-06	7.78e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MYC—malignant glioma	7.86e-06	7.72e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EGFR—malignant glioma	7.69e-06	7.55e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPARG—malignant glioma	7.65e-06	7.51e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CB—malignant glioma	7.46e-06	7.33e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS2—malignant glioma	7.39e-06	7.26e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—KRAS—malignant glioma	7.27e-06	7.13e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CA—malignant glioma	7.04e-06	6.92e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CD—malignant glioma	6.97e-06	6.84e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PIK3CA—malignant glioma	6.68e-06	6.56e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTEN—malignant glioma	6.45e-06	6.33e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CB—malignant glioma	6.07e-06	5.96e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS2—malignant glioma	6.02e-06	5.91e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—AKT1—malignant glioma	5.75e-06	5.65e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CA—malignant glioma	5.59e-06	5.49e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—AKT1—malignant glioma	5.45e-06	5.35e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTEN—malignant glioma	5.25e-06	5.15e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—AKT1—malignant glioma	4.57e-06	4.48e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CA—malignant glioma	4.55e-06	4.47e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—AKT1—malignant glioma	3.72e-06	3.65e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.7e-06	3.64e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—AKT1—malignant glioma	3.02e-06	2.97e-05	CbGpPWpGaD
